Cancer Policy
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Cancer Policy
Jun 27, 2024, 03:05 |
Blog
Andreas Charalambous: It’s a privilege to bring the ECO perspective on the digital health agenda across Europe
Andreas Charalambous, Founder and Chair of European Cancer Communities Foundation, shared a post by Hellenic…
Jun 15, 2024, 06:48 |
Blog
By activating grassroots volunteers nationwide ACS CAN fights cancer in city halls, statehouses, and Congress
Lisa A. Lacasse, President at American Cancer Society Cancer Action Network, shared a post by American…
May 22, 2024, 11:43 |
Blog
Riccardo Moschetti: Back in Bratislava after one year to present progress in cancer prevention
Riccardo Moschetti, Policy Officer at European Cancer Organisation, shared a post by European Cancer Organisation…
Mar 30, 2024, 14:53 |
Blog
Julie Gralow: Super fun and productive visit to Kingston and Queen's University Faculty of Health Sciences, Queen's University Department of Oncology
Julie Gralow recently shared on X: "Super fun and productive visit to Kingston and Queen's University…
Sep 11, 2023, 00:17 |
Blog
Françoise Meunier: I am organizing a High-Level Conference on Ending Financial Discrimination Against Cancer Survivors which will take place in Brussels on 15 February 2024.
Aug 11, 2023, 17:56 |
Blog
Richard Sullivan, director of the Institute of Cancer Policy, will be among the featured speakers on the future of cancer care in Europe - European Cancer Organisation
Proud to announce: Richard Sullivan, director of the Institute of Cancer Policy, will be among…
All:
6
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube